BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3526163)

  • 1. Monitoring of effects of cis-diamminedichloroplatinum (II). Part III. Effect of platinum complexes on PHA-stimulated proliferation of human peripheral blood mononuclear cells in vitro.
    Vancurová M; Procházková J; Krejsek J
    Neoplasma; 1986; 33(3):345-53. PubMed ID: 3526163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells.
    Micetich KC; Barnes D; Erickson LC
    Cancer Res; 1985 Sep; 45(9):4043-7. PubMed ID: 3896476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of effects of cis-diamminedichloroplatinum (II). Part V. Comparison of in vitro Pt-cytostatic effect on blastic transformation of human and murine cells.
    Kanková-Vancurová M; Procházková J
    Neoplasma; 1991; 38(2):213-21. PubMed ID: 2041580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of pre-mRNA splicing by cisplatin and platinum analogs.
    Schmittgen TD; Ju JF; Danenberg KD; Danenberg PV
    Int J Oncol; 2003 Sep; 23(3):785-9. PubMed ID: 12888918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.
    Terheggen PM; Dijkman R; Begg AC; Dubbelman R; Floot BG; Hart AA; den Engelse L
    Cancer Res; 1988 Oct; 48(19):5597-603. PubMed ID: 3046743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of effects of cis-diamminedichloroplatinum (II). IV. In vivo effect of cis-diamminedichloroplatinum (II) on the function of mouse spleen cells: antibody formation and cell proliferation.
    Procházková J; Vancurová M; Matásková H; Púcat P
    Neoplasma; 1988; 35(1):15-26. PubMed ID: 3352834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.
    Holzer AK; Manorek GH; Howell SB
    Mol Pharmacol; 2006 Oct; 70(4):1390-4. PubMed ID: 16847145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cis-DDP and Pt mercaptopyridine complexes on cell lines in vitro.
    Mazzo M; Cherchi V; Nicolini M; Sindellari L; Sitran S; Manchiaro P; D'Ancona S; Berti T
    Farmaco; 1993 Dec; 48(12):1631-40. PubMed ID: 8135987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum cytostatics influence--the primary antibody response of mouse spleen cells in vitro.
    Vancurová M; Procházková J; Nováková M; Blahuta Z
    Neoplasma; 1987; 34(3):277-85. PubMed ID: 3302736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of in vitro gold sodium thiomalate on the stimulation of human peripheral blood mononuclear cells by Mycoplasma arthritidis T cell mitogen, concanavalin A and phytohemagglutinin.
    Cannon GW; Cole BC; Ward JR
    J Rheumatol; 1986 Feb; 13(1):52-7. PubMed ID: 3084780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum(II).
    Kleinerman ES; Zwelling LA; Muchmore AV
    Cancer Res; 1980 Sep; 40(9):3099-102. PubMed ID: 6448684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
    Tenorio EP; Saavedra R
    Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
    Teicher BA; Holden SA; Kelley MJ; Shea TC; Cucchi CA; Rosowsky A; Henner WD; Frei E
    Cancer Res; 1987 Jan; 47(2):388-93. PubMed ID: 3539321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Platinum complexes as radiosensitizers in radiotherapy].
    López Zúmel MC; Alvarez MV; Santos Peinado L
    Rev Esp Oncol; 1984; 31(2):227-36. PubMed ID: 6100707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome aberration and mitotic activity in human peripheral blood lymphocytes following in vitro action of platinum cytostatics cis-DDP and EM-Pt.
    Srb V; Kubzová E; Kubíková K
    Neoplasma; 1986; 33(4):465-9. PubMed ID: 3762807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flameless atomic absorption spectrophotometry analysis of cell-linked platinum after wet ashing.
    Tabary T; Millart H
    Anticancer Res; 1991; 11(1):343-6. PubMed ID: 2018370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts.
    Roberts JJ; Friedlos F
    Cancer Res; 1987 Jan; 47(1):31-6. PubMed ID: 3791217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs.
    Hacker MP; Khokhar AR; Brown DB; McCormack JJ; Krakoff IH
    Cancer Res; 1985 Oct; 45(10):4748-53. PubMed ID: 4040806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of in vitro methods in the immunotoxicologic evaluation of drugs].
    Vancurová M; Jílek P; Procházková J; Chýlková V
    Cesk Farm; 1989 Jul; 38(6):269-71. PubMed ID: 2790994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.